| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |